Njira L Lugogo MD
Asthma & COPD
Professor of Medicine, University of Michigan
Join to View Full Profile
380 Parkland PlazaAnn Arbor, MI 48103
Phone+1 734-998-7380
Dr. Lugogo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Clinical Expertise
- Refractory asthma
Education & Training
Duke University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2007
Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 2001 - 2004
Virginia Commonwealth University School of MedicineClass of 2001
Certifications & Licensure
MI State Medical License 2017 - 2027
NC State Medical License 2001 - 2018
American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Fellows Teaching Award Pulmonary Division, University of Michigan, 2019
Clinical Trials
- Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma Start of enrollment: 2013 Mar 01
- PackHealth: Asthma Engagement Tool Start of enrollment: 2015 Aug 01
- Expansion of the COPD At-risk Module in 4 States BRFSS Telephone Health Surveys Start of enrollment: 2015 Jan 01
Publications & Presentations
PubMed
- Asthma in the Biologics Era: Should OCS Therapy be Relegated to History?Florence Schleich, John J Oppenheimer, Guy Brusselle, Liam G Heaney, William W Busse
The Journal of Allergy and Clinical Immunology. in Practice. 2025-04-11 - 1 citationsInternational Severe Asthma Registry (ISAR): 2017-2024 Status and Progress Update.Désirée Larenas-Linnemann, Chin Kook Rhee, Alan Altraja, John Busby, Trung N Tran
Tuberculosis and Respiratory Diseases. 2025-04-01 - 1 citationsEffect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, plac...Mario Castro, Alberto Papi, Celeste Porsbjerg, Njira L Lugogo, Christopher E Brightling
The Lancet. Respiratory Medicine. 2025-03-01
Press Mentions
Dupilumab Reduces Airway Inflammation, Mucus Plugging in Moderate to Severe AsthmaFebruary 27th, 2024- NAVIGATOR Steers Uncontrolled Asthma Toward Calmer SeasMay 18th, 2022
- NAVIGATOR: Nearly Half of Patients with Severe, Uncontrolled Asthma Improved with TezepelumabMay 17th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
